Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Correlation of Fecal Microbiome and Its Metabolites With Outcome of Radiotherapy in Head and Neck Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acupuncture for Dysphagia in Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of NX-1607 in Adults With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Sleep and Circadian Rhythm Study in Head and Neck Cancer Patients
- Status
- WITHDRAWN
- Phase
- NA
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
- Status
- COMPLETED
- Phase
- PHASE2
Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Single Modality Trans Oral Robotic Surgery for Primary Oropharyngeal Cancer: Exploring the Impact of Surgical Margins on Local Disease Recurrence
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC
- Status
- RECRUITING
- Phase
- NA
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
- Status
- RECRUITING
- Phase
- PHASE3
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
- Status
- RECRUITING
- Phase
- NA
Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery
- Status
- UNKNOWN
- Phase
- PHASE2